ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Sunday, 8 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Board Meeting Outcome

Valiant Laboratories Board Meeting Outcome

Valiant Laboratories approved the re-appointment of directors and a ₹60 Crore investment in its subsidiary, Valiant Advanced Sciences, alongside office relocation plans.

Key figures
Value₹60.00 Cr
Source

NSE filing, NSE: VALIANTLAB. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Valiant Laboratories Ltd: key numbers

Share price
₹116.10
Market cap
₹630.6 Cr
Revenue (annual)
₹237.5 Cr
Net profit (annual)
₹-3.27 Cr
P/E (TTM)
38.9×Sector 43.0×
Promoter holding
74.94%+0.00% QoQ
FII holding
0.07%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Valiant Laboratories Ltd

All →

Other board meeting outcome announcements

All →